Your browser doesn't support javascript.
loading
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
Hodgson, Susanne H; Choudhary, Prateek; Elias, Sean C; Milne, Kathryn H; Rampling, Thomas W; Biswas, Sumi; Poulton, Ian D; Miura, Kazutoyo; Douglas, Alexander D; Alanine, Daniel Gw; Illingworth, Joseph J; de Cassan, Simone C; Zhu, Daming; Nicosia, Alfredo; Long, Carole A; Moyle, Sarah; Berrie, Eleanor; Lawrie, Alison M; Wu, Yimin; Ellis, Ruth D; Hill, Adrian V S; Draper, Simon J.
Afiliación
  • Hodgson SH; The Jenner Institute Laboratories, University of Oxford, Oxford, UK; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, UK. Electronic address: susanne.hodgson@ndm.ox.ac.uk.
  • Choudhary P; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Elias SC; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Milne KH; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Rampling TW; The Jenner Institute Laboratories, University of Oxford, Oxford, UK; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, UK.
  • Biswas S; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Poulton ID; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, UK.
  • Miura K; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Douglas AD; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Alanine DG; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Illingworth JJ; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • de Cassan SC; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Zhu D; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Nicosia A; Okairòs, Rome, Italy; CEINGE, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
  • Long CA; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA.
  • Moyle S; Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, UK.
  • Berrie E; Clinical Biomanufacturing Facility, University of Oxford, Churchill Hospital, Oxford, UK.
  • Lawrie AM; Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Churchill Hospital, Oxford, UK.
  • Wu Y; Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH, Rockville, Maryland, USA.
  • Ellis RD; Laboratory of Malaria Immunology and Vaccinology, NIAID/NIH, Rockville, Maryland, USA.
  • Hill AVS; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
  • Draper SJ; The Jenner Institute Laboratories, University of Oxford, Oxford, UK.
Mol Ther ; 22(12): 2142-2154, 2014 Dec.
Article en En | MEDLINE | ID: mdl-25156127
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Adyuvantes Inmunológicos / Malaria Falciparum / Vacunas contra la Malaria / Antígenos de Protozoos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Plasmodium falciparum / Adyuvantes Inmunológicos / Malaria Falciparum / Vacunas contra la Malaria / Antígenos de Protozoos Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male / Middle aged Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2014 Tipo del documento: Article